1. Homepage
  2. Equities
  3. China
  4. Shanghai Stock Exchange
  5. Guangzhou Kingmed Diagnostics Group Co., Ltd.
  6. News
  7. Summary
    603882   CNE100002VW1

GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD.

(603882)
  Report
End-of-day quote Shanghai Stock Exchange  -  05-19
82.72 CNY   +1.62%
04/29UBS Adjusts Guangzhou Kingmed Diagnostics' Price Target to 97 Yuan From 100 Yuan, Keeps at Buy
MT
04/26Guangzhou Kingmed Diagnostics Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
04/20UBS Adjusts Guangzhou Kingmed Diagnostics' Price Target to 100 Yuan From 230 Yuan, Keeps at Buy
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Guangzhou Kingmed Diagnostics' Shareholder to Unload Up to 6% Stake

06/08/2021 | 04:11am EDT

Guangzhou Kingmed Diagnostics Group Co., Ltd. (SHSE:603882) said equity investment fund plans to unload up to 6% stake in the company between July 1 and December 31.


© S&P Capital IQ 2021
All news about GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD.
04/29UBS Adjusts Guangzhou Kingmed Diagnostics' Price Target to 97 Yuan From 100 Yuan, Keeps..
MT
04/26Guangzhou Kingmed Diagnostics Group Co., Ltd. Reports Earnings Results for the First Qu..
CI
04/20UBS Adjusts Guangzhou Kingmed Diagnostics' Price Target to 100 Yuan From 230 Yuan, Keep..
MT
01/12China's Tianjin outbreak grows as Omicron spreads to Dalian
RE
2021Guangzhou Kingmed Diagnostics Group Co., Ltd. Reports Earnings Results for the Nine Mon..
CI
2021Guangzhou Kingmed Diagnostics Group Co., Ltd. Reports Earnings Results for the Half Yea..
CI
2021China stocks slip as healthcare firms retreat; Hong Kong up
RE
2021GUANGZHOU KINGMED DIAGNOSTICS GROUP : 603882) added to Shanghai Stock Exchange 180 Value ..
CI
2021Guangzhou Kingmed Diagnostics' Shareholder to Unload Up to 6% Stake
CI
2021Guangzhou Kingmed Diagnostics Group Co., Ltd. Reports Earnings Results for the First Qu..
CI
More news
Analyst Recommendations on GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD.
More recommendations
Financials
Sales 2022 14 464 M 2 161 M 2 161 M
Net income 2022 2 566 M 383 M 383 M
Net cash 2022 3 928 M 587 M 587 M
P/E ratio 2022 14,8x
Yield 2022 1,06%
Capitalization 38 530 M 5 757 M 5 757 M
EV / Sales 2022 2,39x
EV / Sales 2023 2,39x
Nbr of Employees 12 371
Free-Float 54,4%
Chart GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD.
Duration : Period :
Guangzhou Kingmed Diagnostics Group Co., Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD.
Short TermMid-TermLong Term
TrendsBullishNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 9
Last Close Price 82,72 CNY
Average target price 123,98 CNY
Spread / Average Target 49,9%
EPS Revisions
Managers and Directors
Yao Ming Liang Chairman & General Manager
Bi Xi Hao CFO, Secretary, Director & Deputy General Manager
Yong Jian Chen Chairman-Supervisory Board
Shi Hui Yu Chief Scientist & Deputy General Manager
Jing Ming Xu Independent Director
Sector and Competitors
1st jan.Capi. (M$)
GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD.-25.73%5 757
SONIC HEALTHCARE LIMITED-21.79%12 176
SYNLAB AG-28.68%3 913
DIAGNOSTICOS DA AMÉRICA S.A.-42.50%2 186
DR. LAL PATHLABS LIMITED-48.59%2 087
HEALIUS LIMITED-20.08%1 706